Overexpression of PI3K p110α contributes to acquired resistance to MET inhibitor, in MET-amplified SNU-5 gastric xenografts
Fujian Ji,1 Xuanwen Liu,2 Yuanyu Wu,1 Xuedong Fang,1 Guomin Huang1 1Department of General Surgery, The China–Japan Union Hospital of Jilin University, Changchun, 2Department of General Surgery, Jilin Central Hospital, Jilin, People’s Republic of China Abstract: Gastric cancer is...
Saved in:
Main Authors: | Ji F (Author), Liu X (Author), Wu Y (Author), Fang X (Author), Huang G (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody
by: Huang L, et al.
Published: (2020) -
New Preclinical Development of a c-Met Inhibitor and Its Combined Anti-Tumor Effect in c-Met-Amplified NSCLC
by: Nam Ah Kim, et al.
Published: (2020) -
The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays
by: Sotoudeh Kambiz, et al.
Published: (2012) -
MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases
by: Shirong Ma, et al.
Published: (2018) -
MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?
by: El Darsa H, et al.
Published: (2020)